AccuStem Sciences reports share purchase by Chairman
Source: SeekingAlpha
2025-04-21 07:53:56 ET
More on AccuStem Sciences, Inc.
Read the full article on Seeking Alpha
For further details see:
AccuStem Sciences reports share purchase by Chairman
Accustem Sciences
NASDAQ: ACUT
ACUT Trading
0.0% G/L:
$0.23 Last:
183 Volume:
$0.23 Open:
ACUT Latest News
January 08, 2026 07:00:00 am
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
September 18, 2025 08:35:00 am
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
September 17, 2025 07:00:00 am
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
September 16, 2025 11:57:15 am
Life Science Virtual Investor Forum Agenda Announced for September 18th
$10,189,817
5,779,215
40.46%
3
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
